Why Wasn't The Approve Trial Stopped Earlier?
The APPROVe trial began enrollment in 2000 and was being monitored by an independent data safety monitoring board (DSMB). It was not stopped earlier because the results for the first 18 months of the trial did not show that Vioxx carried any increased risk of cardiovascular events.
Other Vioxx FAQs
Drug Recalls Sub-categories